Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?

80Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

Objective: In patients with ischemic cardiomyopathy and a substantial amount of dysfunctional but viable myocardium, myocardial revascularization may improve left ventricular ejection fraction. The aim of this study was to evaluate why not all patients with a substantial amount of viable tissue recover in function after revascularization. Methods: A total of 118 consecutive patients with a depressed left ventricular ejection fraction (on average 29% ± 6%) due to chronic coronary artery disease underwent myocardial revascularization. Before revascularization all patients underwent dobutamine stress echocardiography to assess regional dysfunction, left ventricular volumes, and myocardial viability as well as radionuclide ventriculography to determine the left ventricular ejection fraction. Next, 3 to 6 months after revascularization, the left ventricular ejection fraction and regional contractile function were reassessed. Improvement of left ventricular ejection fraction ≥ 5% following revascularization was considered clinically significant. Results: Dobutamine stress echocardiography revealed that 489 (37%) of the 1329 dysfunctional segments were viable. A total of 61 (52%) patients had a substantial amount of viable myocardium (≥ 4 viable segments). In these 61 patients the global function was expected to recover ≥ 5% after revascularization. However, left ventricular ejection fraction did not improve in 20 (33%) of 61 patients despite the presence of substantial viability. Clinical characteristics and echocardiographic data were comparable between patients with and without improvement. However, patients without improvement had considerably larger end systolic volumes (153 ± 41 mL vs 133 ± 46 mL, P = .007). The likelihood of recovery of global function decreased proportionally with the increase of end systolic volume (P < .001, R = 0.43, n = 61). Receiver operating characteristic curve analysis demonstrated that an end systolic volume ≥ 140 mL had the highest sensitivity/specificity to predict the absence of global recovery. Conclusions: In patients with ischemic cardiomyopathy not only the amount of dysfunctional but viable myocardium but also the extent of left ventricular remodeling determines the improvement in function following myocardial revascularization. Patients with a high end systolic volume due to left ventricular remodeling have a decreased likelihood of improvement of global function.

Cite

CITATION STYLE

APA

Schinkel, A. F. L., Poldermans, D., Rizzello, V., Vanoverschelde, J. L. J., Elhendy, A., Boersma, E., … Bax, J. J. (2004). Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization? Journal of Thoracic and Cardiovascular Surgery, 127(2), 385–390. https://doi.org/10.1016/j.jtcvs.2003.08.005

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free